Dr. Maria Caridad Sciame is a pharmacist who is specialized in Pharmacotherapy in Bradenton, Florida. Patients can reach her at 10077 Cherry Hills Avenue Cir, Bradenton or contact her on 941-358-7282. Active license number of Dr. Maria Caridad Sciame is PS32764 for Pharmacotherapy in Florida. Dr. Maria Caridad Sciame is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Maria Caridad Sciame speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Maria Caridad Sciame are as mentioned below.
NPI Number:
1689609349
NPI Enumeration Date:
11 Jul, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Maria Caridad Sciame are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
PS32764
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
10077 Cherry Hills Avenue Cir, Bradenton, Florida
Zip:
34202-4059
Phone Number:
941-358-7282
Fax Number:
--
Patients can reach Dr. Maria Caridad Sciame at 10077 Cherry Hills Avenue Cir, Bradenton, Florida or can call on phone at 941-358-7282.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.